share_log

KalVista Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TCG Crossover GP I, LLC(6.52%),TCG Crossover Fund I, L.P.(6.52%), etc.

SEC announcement ·  Feb 20 16:54
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more